{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:44:13Z","timestamp":1791110653905,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1038\/s12276-019-0220-8","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T11:48:29Z","timestamp":1551181709000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Hypermethylation of Frizzled1 is associated with Wnt\/\u03b2-catenin signaling inactivation in mesenchymal stem cells of patients with steroid-associated osteonecrosis"],"prefix":"10.1038","volume":"51","author":[{"given":"Fei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,26]]},"reference":[{"key":"220_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00776-007-1129-y","volume":"12","author":"M Murata","year":"2007","unstructured":"Murata, M., Kumagai, K., Miyata, N., Osaki, M. & Shindo, H. Osteonecrosis in stroke-prone spontaneously hypertensive rats: effect of glucocorticoid. J. Orthop. Sci. 12, 289\u2013295 (2007).","journal-title":"J. Orthop. Sci."},{"key":"220_CR2","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s11999-008-0171-1","volume":"466","author":"CH Yeh","year":"2008","unstructured":"Yeh, C. H., Chang, J. K., Wang, Y. H., Ho, M. L. & Wang, G. J. Ethanol may suppress Wnt\/beta-catenin signaling on human bone marrow stroma cells: a preliminary study. Clin. Orthop. Relat. Res. 466, 1047\u20131053 (2008).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"220_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.aanat.2009.09.006","volume":"192","author":"W Drescher","year":"2010","unstructured":"Drescher, W. et al. Enhanced constriction of supplying arteries-a mechanism of femoral head necrosis in Wistar rats? Ann. Anat. 192, 58\u201361 (2010).","journal-title":"Ann. Anat."},{"key":"220_CR4","first-page":"162","volume":"88","author":"W Drescher","year":"2006","unstructured":"Drescher, W. et al. Femoral artery constriction by norepinephrine is enhanced by methylprednisolone in a rat model. J. Bone Jt. Surg. Am. 88, 162\u2013166 (2006).","journal-title":"J. Bone Jt. Surg. Am."},{"key":"220_CR5","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s00256-002-0531-y","volume":"31","author":"WP Chan","year":"2002","unstructured":"Chan, W. P. et al. MRI of joint fluid in femoral head osteonecrosis. Skelet. Radiol. 31, 624\u2013630 (2002).","journal-title":"Skelet. Radiol."},{"key":"220_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10238-003-0016-x","volume":"3","author":"MJ Cuadrado","year":"2003","unstructured":"Cuadrado, M. J. & Lopez-Pedrera, C. Antiphospholipid syndrome. Clin. Exp. Med 3, 129\u2013139 (2003).","journal-title":"Clin. Exp. Med"},{"key":"220_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00774-008-0019-5","volume":"27","author":"SI Yun","year":"2009","unstructured":"Yun, S. I., Yoon, H. Y., Jeong, S. Y. & Chung, Y. S. Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3beta. J. Bone Miner. Metab. 27, 140\u2013148 (2009).","journal-title":"J. Bone Miner. Metab."},{"key":"220_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jbspin.2012.02.015","volume":"80","author":"C Chen","year":"2012","unstructured":"Chen, C. et al. Impairment of two types of circulating endothelial progenitor cells in patients with glucocorticoid-induced avascular osteonecrosis of the femoral head. Joint Bone Spine 80, 70\u201376 (2012).","journal-title":"Joint Bone Spine"},{"key":"220_CR9","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1007\/s11999-009-1076-3","volume":"467","author":"D Varoga","year":"2009","unstructured":"Varoga, D., Drescher, W., Pufe, M., Groth, G. & Pufe, T. Differential expression of vascular endothelial growth factor in glucocorticoid-related osteonecrosis of the femoral head. Clin. Orthop. Relat. Res 467, 3273\u20133282 (2009).","journal-title":"Clin. Orthop. Relat. Res"},{"key":"220_CR10","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.3899\/jrheum.130191","volume":"40","author":"Z Sun","year":"2013","unstructured":"Sun, Z. et al. Aberrant CpG islands hypermethylation of ABCB1 in mesenchymal stem cells of patients with steroid-associated osteonecrosis. J. Rheumatol. 40, 1913\u20131920 (2013).","journal-title":"J. Rheumatol."},{"key":"220_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00198-014-2809-z","volume":"26","author":"Z Sun","year":"2015","unstructured":"Sun, Z. et al. Icariin may benefit the mesenchymal stem cells of patients with steroid-associated osteonecrosis by ABCB1-promoter demethylation: a preliminary study. Osteoporos. Int 26, 187\u2013197 (2015).","journal-title":"Osteoporos. Int"},{"key":"220_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/srep22599","volume":"6","author":"C Hao","year":"2016","unstructured":"Hao, C. et al. MiR-708 promotes steroid-induced osteonecrosis of femoral head, suppresses osteogenic differentiation by targeting SMAD3. Sci. Rep. 6, 22599 (2016).","journal-title":"Sci. Rep."},{"key":"220_CR13","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/term.1999","volume":"11","author":"D Kai","year":"2017","unstructured":"Kai, D., Prabhakaran, M. P., Jin, G., Tian, L. & Ramakrishna, S. Potential of VEGF-encapsulated electrospun nanofibers for in vitro cardiomyogenic differentiation of human mesenchymal stem cells. J. Tissue Eng. Regen. Med. 11, 1002\u20131010 (2017).","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"220_CR14","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/dgd.12009","volume":"54","author":"Z Sun","year":"2012","unstructured":"Sun, Z. et al. Growth differentiation factor 5 modulation of chondrogenesis of self-assembled constructs involves gap junction-mediated intercellular communication. Dev. Growth Differ. 54, 809\u2013817 (2012).","journal-title":"Dev. Growth Differ."},{"key":"220_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s40659-017-0148-1","volume":"50","author":"A Madrigal","year":"2017","unstructured":"Madrigal, A., Tan, L. & Zhao, Y. Expression regulation and functional analysis of RGS2 and RGS4 in adipogenic and osteogenic differentiation of human mesenchymal stem cells. Biol. Res. 50, 43 (2017).","journal-title":"Biol. Res."},{"key":"220_CR16","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1177\/0192623317738170","volume":"45","author":"WA Bullock","year":"2017","unstructured":"Bullock, W. A. & Robling, A. G. WNT-mediated Modulation of Bone Metabolism: Implications for WNT Targeting to Treat Extra skeletal Disorders. Toxicol. Pathol. 45, 864\u2013868 (2017).","journal-title":"Toxicol. Pathol."},{"key":"220_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2174\/1574888X12666171012141908","volume":"13","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. PPAR-\u03b3 and Wnt Regulate the Differentiation of MSCs into Adipocytes and Osteoblasts Respectively. Curr. Stem Cell Res Ther. 13, 185\u2013192 (2018).","journal-title":"Curr. Stem Cell Res Ther."},{"key":"220_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.biomaterials.2017.08.031","volume":"145","author":"R Li","year":"2017","unstructured":"Li, R. et al. Self-assembled N-cadherin mimetic peptide hydrogels promote the chondrogenesis of mesenchymal stem cells through inhibition of canonical Wnt\/\u03b2-catenin signaling. Biomaterials 145, 33\u201343 (2017).","journal-title":"Biomaterials"},{"key":"220_CR19","first-page":"4777","volume":"21","author":"JP Li","year":"2017","unstructured":"Li, J. P., Zhuang, H. T., Xin, M. Y. & Zhou, Y. L. MiR-214 inhibits human mesenchymal stem cells differentiating into osteoblasts through targeting \u03b2-catenin. Eur. Rev. Med. Pharmacol. Sci. 21, 4777\u20134783 (2017).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"220_CR20","doi-asserted-by":"publisher","first-page":"12667","DOI":"10.1074\/jbc.M117.777581","volume":"292","author":"ML Xu","year":"2017","unstructured":"Xu, M. L., Bi, C. W. C., Liu, E. Y. L., Dong, T. T. X. & Tsim, K. W. K. Wnt3a induces the expression of acetylcholinesterase during osteoblast differentiation via the Runx2 transcription factor. J. Biol. Chem. 292, 12667\u201312678 (2017).","journal-title":"J. Biol. Chem."},{"key":"220_CR21","doi-asserted-by":"publisher","first-page":"e0163277","DOI":"10.1371\/journal.pone.0163277","volume":"11","author":"S Yu","year":"2016","unstructured":"Yu, S., Yerges-Armstrong, L. M., Chu, Y., Zmuda, J. M. & Zhang, Y. Transcriptional Regulation of Frizzled-1 in Human Osteoblasts by Sp1. PLoS ONE 11, e0163277 (2016).","journal-title":"PLoS ONE"},{"key":"220_CR22","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.bone.2013.06.019","volume":"56","author":"S Yu","year":"2013","unstructured":"Yu, S., Yerges-Armstrong, L. M., Chu, Y., Zmuda, J. M. & Zhang, Y. E2F1 effects on osteoblast differentiation and mineralization are mediated through up-regulation of frizzled-1. Bone 56, 234\u2013241 (2013).","journal-title":"Bone"},{"key":"220_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1042\/BJ20140668","volume":"465","author":"S Yu","year":"2015","unstructured":"Yu, S., Yerges-Armstrong, L. M., Chu, Y., Zmuda, J. M. & Zhang, Y. AP2 suppresses osteoblast differentiation and mineralization through down-regulation of Frizzled-1. Biochem J. 465, 395\u2013404 (2015).","journal-title":"Biochem J."},{"key":"220_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1359\/jbmr.080816","volume":"24","author":"LM Yerges","year":"2009","unstructured":"Yerges, L. M. et al. Functional characterization of genetic variation in the Frizzled 1 (FZD1) promoter and association with bone phenotypes: more to the LRP5 story? J. Bone Miner. Res 24, 87\u201396 (2009).","journal-title":"J. Bone Miner. Res"},{"key":"220_CR25","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.bone.2009.12.026","volume":"46","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. et al. Functional and association analysis of frizzled 1 (FZD1) promoter haplotypes with femoral neck geometry. Bone 46, 1131\u20131137 (2010).","journal-title":"Bone"},{"key":"220_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s100670200078","volume":"21","author":"KH Koo","year":"2002","unstructured":"Koo, K. H. et al. Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment. Clin. Rheumatol. 21, 299\u2013303 (2002).","journal-title":"Clin. Rheumatol."},{"key":"220_CR27","doi-asserted-by":"publisher","first-page":"2B.9.1","DOI":"10.1002\/cpsc.43","volume":"44","author":"D Vivas","year":"2018","unstructured":"Vivas, D., Caminal, M., Oliver-Vila, I. & Vives, J. Derivation of multipotent mesenchymal stromal cells from ovine bone marrow. Curr. Protoc. Stem Cell Biol. 44, 2B.9.1\u20132B.9.22 (2018).","journal-title":"Curr. Protoc. Stem Cell Biol."},{"key":"220_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40883-018-0047-1","volume":"4","author":"Z Sun","year":"2018","unstructured":"Sun, Z., Nair, L. S. & Laurencin, C. T. The paracrine effect of adipose-derived stem cells inhibits IL-1\u03b2-induced inflammation in chondrogenic cells through the Wnt\/\u03b2-catenin signaling pathway. Regen. Eng. Transl. Med 4, 35\u201341 (2018).","journal-title":"Regen. Eng. Transl. Med"},{"key":"220_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.biocel.2011.11.013","volume":"44","author":"WH Yu","year":"2012","unstructured":"Yu, W. H. et al. PPAR\u03b3 suppression inhibits adipogenesis but does not promote osteogenesis of human mesenchymal stem cells. Int J. Biochem Cell Biol. 44, 377\u2013384 (2012).","journal-title":"Int J. Biochem Cell Biol."},{"key":"220_CR30","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/ng.298","volume":"41","author":"RA Irizarry","year":"2009","unstructured":"Irizarry, R. A. et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet 41, 178\u2013186 (2009).","journal-title":"Nat. Genet"},{"key":"220_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-015-0606-2","volume":"16","author":"C Zhang","year":"2015","unstructured":"Zhang, C., Zou, Y. L., Ma, J., Dang, X. Q. & Wang, K. Z. Apoptosis associated with Wnt\/ \u03b2-catenin pathway leads to steroid-induced avascular necrosis of femoral head. BMC Musculoskelet. Disord. 16, 132 (2015).","journal-title":"BMC Musculoskelet. Disord."},{"key":"220_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.3074","volume":"19","author":"R Baron","year":"2013","unstructured":"Baron, R. & Kneissel, M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat. Med 19, 179\u2013192 (2013).","journal-title":"Nat. Med"},{"key":"220_CR33","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bone.2009.10.030","volume":"46","author":"JY Ko","year":"2010","unstructured":"Ko, J. Y. et al. Increased Dickkopf-1 expression accelerates bone cell apoptosis in femoral head osteonecrosis. Bone 46, 584\u2013591 (2010).","journal-title":"Bone"},{"key":"220_CR34","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.gene.2013.05.044","volume":"526","author":"D Abbey","year":"2013","unstructured":"Abbey, D. & Seshagiri, P. B. Aza-induced cardiomyocyte differentiation of P19 EC-cells by epigenetic co-regulation and ERK signaling. Gene 526, 364\u2013373 (2013).","journal-title":"Gene"},{"key":"220_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3389\/fgene.2018.00419","volume":"9","author":"F Diomede","year":"2018","unstructured":"Diomede, F. et al. 5-aza exposure improves reprogramming process through embryoid body formation in human gingival stem cells. Front Genet 9, 419 (2018).","journal-title":"Front Genet"},{"key":"220_CR36","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/jcp.25183","volume":"231","author":"YD Cho","year":"2016","unstructured":"Cho, Y. D. et al. Epigenetic priming confers direct cell trans-differentiation from adipocyte to osteoblast in a transgene-free state. J. Cell Physiol. 231, 1484\u20131494 (2016).","journal-title":"J. Cell Physiol."},{"key":"220_CR37","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/jcmm.12972","volume":"21","author":"K Kornicka","year":"2017","unstructured":"Kornicka, K., Marycz, K., Mar\u0119dziak, M., Tomaszewski, K. A. & Nicpo\u0144, J. The effects of the DNA methyltranfserases inhibitor 5-Azacitidine on ageing, oxidative stress and DNA methylation of adipose derived stem cells. J. Cell Mol. Med. 21, 387\u2013401 (2017).","journal-title":"J. Cell Mol. Med."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s12276-019-0220-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-019-0220-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-019-0220-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:10:27Z","timestamp":1684617027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-019-0220-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["220"],"URL":"https:\/\/doi.org\/10.1038\/s12276-019-0220-8","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"28 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}